Visiting Scholar - Cancer Genomics & Immunology Research

Ohio State University; Columbus (OH); On-site; USD 60,000 - 90,000; Full time

Job summary

The Ohio State University seeks a Visiting Scholar in Medical Oncology to conduct cancer research in Hasanov Lab at PIIO. You will analyze high-dimensional omics data, collaborate across disciplines, and contribute to translational cancer immunology projects.

Required MD or PhD with strong programming skills (Python/R/Perl) and a track record of publications. This fixed-term position emphasizes collaboration, innovation, and advancing cancer therapies within a renowned cancer center.

Qualifications

• MD or PhD in computational biology, population genetics/genomics, bioinformatics, or biostatistics.
• Proficiency in Python, R, or Perl.
• Experience with single-cell and spatial data analysis tools.
• Strong publication record and excellent communication skills, both written and verbal.

Responsibilities

• Process, analyze, and interpret high-dimensional data from various omics platforms.
• Collaborate closely with multidisciplinary teams to answer crucial questions in tumor biology and immunology.
• Publish research findings in high-impact journals and provide bioinformatics support to the team.
• Assist with data integration and training within PIIO and the lab.

Skills

Bioinformatics

Tumor biology

Publication track record

Communication skills

Team collaboration

Python

R

Perl

Education

MD or PhD in computational biology/genomics/bioinformatics/biostatistics

Tools

Seurat

Scanpy

Single-cell analysis tools

Spatial data analysis tools

Job description

The Ohio State University seeks a Visiting Scholar in Medical Oncology to conduct cancer research in Hasanov Lab at PIIO. You will analyze high-dimensional omics data, collaborate across disciplines, and contribute to translational cancer immunology projects.

Required MD or PhD with strong programming skills (Python/R/Perl) and a track record of publications. This fixed-term position emphasizes collaboration, innovation, and advancing cancer therapies within a renowned cancer center.